An unaerated ice-containing product is provided which comprises at -18°C, a first population of frozen particles having a particle size of greater than 0.5 mm and a second population of frozen particles having a mean particle size such that the ratio of the mean particle size for the first population to the mean particle size for the second population is greater than 10 and less than 100, wherein ...

A method of treating a vertebra, comprising: (a) accessing an interior of a vertebra; and (b) introducing a sufficient amount of artificial biocompatible material which does not set to a hardened condition in storage, into said bone, with sufficient force to move apart fractured portions of said bone.

A garment hanger having a releasable size indicator. The garment hanger including a hook for suspending the hanger on a support and a body connected to the hook; the hanger having at least one web for removably securing a size indicator to the hanger, the web having a fixed latch and a pivoting latch; and a size indicator having a triangular cross-section and fingers for engaging the fixed and piv...

Compounds, compositions and methods for treatment of hyperproliferative diseases, such as cancer are provided. or a pharmaceutically acceptable derivative thereof, where: M is CO, SO or SO 2 ; R 1s and R 2s are selected as follows: (i) R 1s is hydrogen, alkyl, alkenyl, alkynyl, aryl, heteroaryl, cycloalkyl or heterocyclyI; and R 2s is selected from hydrogen, alkenyl, alkynyl, aryl, heter...

The present invention provides a recombinant toxin or the subunit B thereof selected from the group consisting of E. coli heat-labile enterotoxin (LT), its subunit B (LTB), cholera toxin (CT) and its subunit B (CTB), in immunogenic form, expressed in eukaryotic cells, a vaccine comprising said toxin or subunit B thereof, and use of said recombinant toxin or subunit B thereof in human or veterinary...

The present disclosure provides compositions, methods, and processes for the inhibiting, destroying, and/or inactivating viral contaminants in a biological source material, or treatment of viral infections. The disclosed compositions include one or more quaternary ammonium compounds. One exemplary method includes contacting the biological source material with a solution containing one or more quat...

A method of performing a ranging process between a base station and a mobile station in sleep mode in a wireless access system, wherein the base station provides the mobile station with an initial notification of a periodic ranging time that occurs during a sleep time interval and during which the mobile station is to perform the ranging process, the initial notification included in a first messag...

Disclosed is a composition comprising: (a) a virus-like particle (VLP) comprising coat proteins, mutants or fragments thereof, of an RNA-bacteriophage with at least one first attachment site, wherein said VLP is recombinantly produced by a host, and said VLP is essentially free of host RNA, and wherein said mutant or said fragment of said coat protein of said RNA-bacteriophage is capable of assemb...

The present invention relates to constructs and methods for the treatment of diseases, disorders and conditions, including those relating to or involving autoimmune disorders, inflammation, bacterial, fungal, and viral infections, and diseases caused by or involving uncontrolled or abnormal proliferation of cells, including cancer.

The present invention is directed to therapeutic compositions targeting the NC Ca-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, agonists and antagonists of the NC CA-ATP channel are contemplated. The therapeutic compositions are used to treat cancer, more specifically, a metastatic brain tumor, wherein a tumor-brain barrier is pre...

A new treatment regime is presenter using a low concentration formulation at a low dosage of hydrophobic photosensitizers (PS) that shows improved pharmacokinetics and an effective method for photodynamic therapy ("PDT"). The new formulation has better pharmacological effect compared to standard photosensitizer formulation with standard dosage. It was found that PDT treatments using the disclosed ...

A process for coating a substrate at atmospheric pressure comprises the steps of vaporizing a controlled mass of semiconductor material at substantially atmospheric pressure within a heated inert gas stream, to create a fluid mixture having a temperature above the condensation temperature of the semiconductor material, directing the fluid mixture at substantially atmospheric pressure onto the subs...

The covering in principle comprises tiles formed by certain bases (1) of a plastic material and upper plaques (2) attached to the bases, the base (1) incorporating male (3) and female (4) anchoring elements via their edges which complement each other in order to engage one tile with another. The improvements are characterised in that the male and female anchoring elements are arranged alternativel...

Previous methods for culturing human embryonic stem cells have required either fibroblast feeder cells or a medium which has been exposed to fibroblast feeder cells in order to maintain the stem cells in an undifferentiated state. It has now been found that if high levels of fibroblast growth factor are used in a medium with gamma amino butyric acid, pipecholic acid, lithium and lipids, the stem c...

Cooling devices, such as a thermally conductive device, systems, and methods for removing heat from subcutaneous lipid-rich cells, and more particularly to a coolant in a flexible membrane wherein the coolant preferably has a phase transition temperature less than or approximately equal to about 0° C. The thermally conductive device may have compartments with varying phase transition temperatures ...

Methods and computer program products for evaluating and optimizing one or more markers for use in establishing a prognosis for a patient suffering from a disease are provided. More particularly, the methods include steps for systematically evaluating a number of features that may be extracted from an image of a body sample, such as a histological slide, that has been exposed to one or more biomar...

The present invention relates to a composition for use against one or more pathogens, comprising at least one antagonistic micro-organism and at least one salt and/or derivatives thereof as defined in claim 1 . The present invention further relates to said composition for use as biopesticide.